Recently, Buttari et al. demonstrated that EVs isolated from RA patients could promote in vitro DC activation by inducing MAPK and NF-κB activation, leading to the pro-inflammatory DC phenotype expressed by the production of IL-12, IL-1β, and IL-10 [155]. Here, NFKB1 is linked to rheumatoid arthritis.